Endostatin's antiangiogenic signaling network

被引:361
作者
Abdollahi, A
Hahnfeldt, P
Maercker, C
Gröne, HJ
Debus, J
Ansorge, W
Folkman, J
Hlatky, L
Huber, PE
机构
[1] Univ Heidelberg, Sch Med, Dept Radiat Oncol, German Canc Res Ctr, Heidelberg, Germany
[2] Univ Heidelberg, Sch Med, Dept Radiat Oncol, Heidelberg, Germany
[3] Harvard Univ, Sch Med, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA USA
[4] German Genome Resource Ctr, Berlin, Germany
[5] German Canc Res Ctr, Dept Mol Pathol, D-6900 Heidelberg, Germany
[6] European Mol Biol Lab, Heidelberg, Germany
[7] Harvard Univ, Sch Med, Surg Res Lab, Dept Surg,Childrens Hosp, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[9] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1016/S1097-2765(04)00102-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is here demonstrated that the set of gene expressions underlying the angiogenic balance in tissues can be molecularly reset en masse by a single protein. Using genome-wide expression profiling, coupled with RT-PCR and phosphorylation analysis, we show that the endogenous angiogenesis inhibitor endostatin down-regulates many signaling pathways in human microvascular endothelium associated with proangiogenic activity. Simultaneously, endostatin is found to upregulate many antiangiogenic genes. The result is a unique alignment between the direction of gene regulation and angiogenic status. Profiling further reveals the regulation of genes not heretofore associated with angiogenesis. Our analysis of coregulated genes shows complex interpathway communications in an intricate signaling network that both recapitulates and extends on current understanding of the angiogenic process. More generally, insights into the nature of genetic networking from the cell biologic and therapeutic perspectives are revealed.
引用
收藏
页码:649 / 663
页数:15
相关论文
共 80 条
  • [1] Abdollahi A, 2003, CANCER RES, V63, P3755
  • [2] Abdollahi A, 2003, CANCER RES, V63, P8890
  • [3] Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
    Bargou, RC
    Emmerich, F
    Krappmann, D
    Bommert, K
    Mapara, MY
    Arnold, W
    Royer, HD
    Grinstein, E
    Greiner, A
    Scheidereit, C
    Dörken, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) : 2961 - 2969
  • [4] Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells
    Bartoli, M
    Gu, XL
    Tsai, NT
    Venema, RC
    Brooks, SE
    Marrero, MB
    Caldwell, RB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) : 33189 - 33192
  • [5] An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
    Beg, AA
    Baltimore, D
    [J]. SCIENCE, 1996, 274 (5288) : 782 - 784
  • [6] THE PROTEIN ID - A NEGATIVE REGULATOR OF HELIX-LOOP-HELIX DNA-BINDING PROTEINS
    BENEZRA, R
    DAVIS, RL
    LOCKSHON, D
    TURNER, DL
    WEINTRAUB, H
    [J]. CELL, 1990, 61 (01) : 49 - 59
  • [7] The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing
    Berger, AC
    Feldman, AL
    Gnant, MFX
    Kruger, EA
    Sim, BKL
    Hewitt, S
    Figg, WD
    Alexander, HR
    Libutti, SK
    [J]. JOURNAL OF SURGICAL RESEARCH, 2000, 91 (01) : 26 - 31
  • [8] Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array
    Boer, JM
    Huber, WK
    Sültmann, H
    Wilmer, F
    von Heydebreck, A
    Haas, S
    Korn, B
    Gunawan, B
    Vente, A
    Füzesi, L
    Vingron, M
    Poustka, A
    [J]. GENOME RESEARCH, 2001, 11 (11) : 1861 - 1870
  • [9] INCREASED T-CELL APOPTOSIS AND TERMINAL B-CELL DIFFERENTIATION-INDUCED BY INACTIVATION OF THE ETS-1 PROTOONCOGENE
    BORIES, JC
    WILLERFORD, DM
    GREVIN, D
    DAVIDSON, L
    CAMUS, A
    MARTIN, P
    STEHELIN, D
    ALT, FW
    [J]. NATURE, 1995, 377 (6550) : 635 - 638
  • [10] STATs in oncogenesis
    Bowman, T
    Garcia, R
    Turkson, J
    Jove, R
    [J]. ONCOGENE, 2000, 19 (21) : 2474 - 2488